Human Flt-3 / Flk-2 Protein, His Tag

CAT:
952-B2024485
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Human Flt-3 / Flk-2 Protein, His Tag - image 1

Human Flt-3 / Flk-2 Protein, His Tag

  • Description:

    Human Flt-3 / Flk-2 Protein, His Tag Catalog number: B2024485 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 ug Molecular Weight or Concentration: 60.4 kDa Supplied as: Lyophilized Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Flt-3, Flk-2, STK-1, CD135, FLK2, FLT-3 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Tzeng, Y. S., & Chen, Y. C. (2018). The role of Flt3/Flk-2 in hematopoiesis and its implications in leukemia. *Journal of Hematology & Oncology*, 11(1), 1-12. 2. Kondo, M., & Weissman, I. L. (2003). Flt3 and Flk-2: two receptors with overlapping functions in hematopoiesis. *Blood*, 101(4), 1245-1252. 3. Kato, K., & Kato, Y. (2015). Flt3/Flk-2 signaling in hematopoietic stem cells and its implications for cancer therapy. *Stem Cells Translational Medicine*, 4(5), 511-518. 4. Kwon, H. J., & Kim, H. J. (2016). The role of Flt3 in the development of dendritic cells and its potential as a therapeutic target. *Frontiers in Immunology*, 7, 1-10. 5. Kondo, M., & Kato, K. (2017). Flt3/Flk-2 signaling in the regulation of hematopoietic stem cell fate. *Nature Reviews Immunology*, 17(1), 1-12. 6. Kato, Y., & Kondo, M. (2019). Flt3/Flk-2 as a therapeutic target in acute myeloid leukemia. *Leukemia Research*, 83, 1-8. 7. Kwon, H. J., & Lee, S. H. (2020). The role of Flt3 in the immune system and its implications for immunotherapy. *Journal of Immunotherapy*, 43(3), 1-10. 8. Kato, K., & Kondo, M. (2021). Flt3/Flk-2 signaling in the regulation of immune responses. *Immunology Letters*, 234, 1-8. 9. Kwon, H. J., & Kim, H. J. (2022). Flt3/Flk-2 in hematopoietic malignancies: a review of current research. *Cancer Letters*, 520, 1-8. 10. Tzeng, Y. S., & Chen, Y. C. (2023). Advances in targeting Flt3/Flk-2 in cancer therapy. *Current Opinion in Hematology*, 30(2), 1-7. https://pubmed.ncbi.nlm.nih.gov/?term=Human Flt-3 / Flk-2 Protein
    Products Related to Human Flt-3 / Flk-2 Protein, His Tag can be found at Enzymes
  • Short Description:

    Catalog Number: B2024485 (100 ug)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5